Minimal residual disease evaluation in autologous stem cell transplantation recipients with multiple myeloma

Autor:	Om Dutt Sharma, Lalit Kumar, Meetu Dahiya, Ritu Gupta, Varun Shekhar, Atul Sharma, P. Harish, Nitin Mathur
Rok vydání:	2016
Předmět:	0301 basic medicine Oncology Cancer Research medicine.medical_specialty Neoplasm Residual Transplantation Conditioning Kaplan-Meier Estimate Transplantation Autologous Immunophenotyping 03 medical and health sciences 0302 clinical medicine Autologous stem-cell transplantation Internal medicine Overall survival Humans Medicine Prospective Studies Multiple myeloma business.industry Hematopoietic Stem Cell Transplantation Hematology Prognosis medicine.disease Minimal residual disease Treatment Outcome 030104 developmental biology Novel agents 030220 oncology & carcinogenesis Multiple Myeloma business
Zdroj:	Leukemia & Lymphoma. 58:1234-1237
ISSN:	1029-2403 1042-8194
DOI:	10.1080/10428194.2016.1228930
Popis:	The use of novel agents for the treatment of multiple myeloma (MM) has enabled attainment of deeper responses and the information that progression-free survival (PFS) and overall survival (OS) corr...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a77cc71294edc2fdb8834e08decbfb https://doi.org/10.1080/10428194.2016.1228930 Zobrazit plný text záznamu